Understanding Dementia and Alzheimer's Disease Dementia is an umbrella term for a group of symptoms characterized by a severe decline in memory, thinking, language, and reasoning that disrupts a person's daily life and independence. It is important to note that dementia is not a normal part of aging; while normal aging may involve occasional forgetfulness or slower processing speeds, it does not impair a person's ability to function independently. Alzheimer's disease is the most common cause of dementia, followed by vascular dementia, Lewy body dementia, and frontotemporal dementia.

The Global Impact Dementia is a rapidly growing global health crisis. Currently, over 55 million people worldwide live with dementia, a figure projected to nearly triple to 150 million by 2050. This takes a massive economic and emotional toll on healthcare systems and, heavily, on unpaid family caregivers.

Prevention and Modifiable Risk Factors According to the 2024 Lancet Commission report, there is significant hope for prevention. Research suggests that nearly 45% of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors throughout a person's life. These include:

• Early Life: Lower levels of education.
• Midlife: Hearing loss, high LDL cholesterol, hypertension, traumatic brain injury (TBI), obesity, and excessive alcohol consumption.
• Late Life: Smoking, depression, physical inactivity, social isolation, diabetes, air pollution, and untreated vision loss.

Addressing these risks, staying physically active, remaining socially engaged, and following diets rich in plant-based foods and healthy fats (like the Mediterranean or MIND diets) help build cognitive reserve. Cognitive reserve is the brain's active ability to compensate for age-related changes and neural damage, allowing a person to maintain cognitive function for longer.

Innovations in Diagnosis Early and accurate diagnosis is crucial for effective care, and recent technological advancements are transforming this field:

• Blood-Based Biomarkers: Innovative blood tests, particularly those measuring the p-tau217 protein, are proving highly accurate in detecting early Alzheimer's disease pathology, offering a cheaper and less invasive alternative to traditional spinal taps or PET scans.
• Artificial Intelligence (AI): AI is revolutionizing diagnosis. AI tools like "StateViewer" can analyze standard brain scans to quickly identify patterns linked to nine different types of dementia. Additionally, passive digital AI markers can seamlessly scan electronic health records to identify early warning signs of dementia without requiring extra time from primary care doctors.